A comprehensive review of the neonatal Fc receptor and its application in drug delivery

Pharmacology and Therapeutics

Volumn 161, Issue , 2016, Pages 22-39

  Martins, João Pedro ^a,b,c   Kennedy, Patrick J ^a,b,c   Santos, Hélder A ^d   Barrias, Cristina ^a,b   Sarmento, Bruno ^a,b,e  

^a UNIVERSITY OF PORTO   (Portugal)

^b INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

Author keywords

Albumin; Drug delivery; FcRn; IgG; Recycling; Transcytosis

Indexed keywords

ALBUMIN; FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; ALBUMINOID; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTING CELL; BLOOD BRAIN BARRIER; BONE; BREAST; DRUG DELIVERY SYSTEM; EYE; GENITAL SYSTEM; HUMAN; INTESTINE; KIDNEY; LIVER; LUNG; PASSIVE IMMUNIZATION; PH; PLACENTA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SKIN; TRANSCYTOSIS; VACCINATION; VASCULAR ENDOTHELIUM; VIRUS NEUTRALIZATION; ANIMAL; BIOSYNTHESIS; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; PROCEDURES; TISSUE DISTRIBUTION;

ALBUMINS; ANIMALS; DRUG DELIVERY SYSTEMS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN G; MOLECULAR TARGETED THERAPY; RECEPTORS, FC; TISSUE DISTRIBUTION;

EID: 84962069586     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.03.007     Document Type: Review

References (234)

1. Y.N. Abdiche, Y.A. Yeung, J. Chaparro-riggers, I. Barman, P. Strop, S.M. Chin, and et al. The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity MAbs 7 2 2015 331 343
2. J.O. Agola, P.A. Jim, H.H. Ward, S. Basuray, and A. Wandinger-Ness Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities Clin Genet 80 4 2011 305 318
3. S. Akilesh, G.J. Christianson, D.C. Roopenian, and A.S. Shaw Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism J Immunol 179 7 2007 4580 4588
4. S. Akilesh, T.B. Huber, H. Wu, G. Wang, B. Hartleben, J.B. Kopp, and et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane Proc Natl Acad Sci U S A 105 3 2008 967 972
5. S. Amsellem, J. Gburek, G. Hamard, R. Nielsen, T.E. Willnow, O. Devuyst, and et al. Cubilin is essential for albumin reabsorption in the renal proximal tubule J Am Soc Nephrol 21 11 2010 1859 1867
6. J.T. Andersen, and I. Sandlie The versatile MHC class I-related FcRn protects IgG and albumin from degradation: Implications for development of new diagnostics and therapeutics Drug Metab Pharmacokinet 24 4 2009 318 332
7. J.T. Andersen, M.B. Daba, and I. Sandlie FcRn binding properties of an abnormal truncated analbuminemic albumin variant Clin Biochem 43 4-5 2010 367 372
8. J.T. Andersen, B. Dalhus, J. Cameron, M.B. Daba, A. Plumridge, L. Evans, and et al. Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor Nat Commun 3 2012 610
9. J.T. Andersen, B. Dalhus, D. Viuff, B.T. Ravn, K.S. Gunnarsen, A. Plumridge, and et al. Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding J Biol Chem 289 19 2014 13492 13502
10. J.T. Andersen, J. Dee Qian, and I. Sandlie The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin Eur J Immunol 36 11 2006 3044 3051
11. J.T. Andersen, M. Gonzalez-Pajuelo, S. Foss, O.J.B. Landsverk, D. Pinto, A. Szyroki, and et al. Selection of nanobodies that target human neonatal Fc receptor Sci Rep 3 2013 1118
12. C.L. Anderson, C. Chaudhury, J. Kim, C.L. Bronson, M.A. Wani, and S. Mohanty Perspective - FcRn transports albumin: Relevance to immunology and medicine Trends Immunol 27 7 2006 343 348
13. Y. Bai, L. Ye, D.B. Tesar, H. Song, D. Zhao, P.J. Bjorkman, and et al. Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport Proc Natl Acad Sci U S A 108 45 2011 18406 18411
14. K. Baker, S.-W. Qiao, T.T. Kuo, V.G. Aveson, B. Platzer, J.-T. Andersen, and et al. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b + dendritic cells Proc Natl Acad Sci U S A 108 24 2011 9927 9932
15. K. Baker, S.-W. Qiao, T. Kuo, K. Kobayashi, M. Yoshida, W.I. Lencer, and et al. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn Semin Immunopathol 31 2 2009 223 236
16. K. Baker, T. Rath, M.B. Flak, J.C. Arthur, Z. Chen, J.N. Glickman, and et al. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer Immunity 39 6 2013 1095 1107
17. K. Baker, T. Rath, M. Pyzik, and R.S. Blumberg The role of FcRn in antigen presentation Front Immunol 5 2014 1 12
18. F.C. Ballantyne, A. Fleck, and W.C. Dick Albumin metabolism in rheumatoid arthritis Ann Rheum Dis 30 3 1971 265 270
19. D.R. Bamford Studies in vitro of the passage of serum proteins across the intestinal wall of young rats Proc R Soc Lond Ser B Biol Sci 166 1002 1966 30 45
20. A. Beck, and J.M. Reichert Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies MAbs 3 5 2011 415 416
21. Y. Ben Suleiman, M. Yoshida, S. Nishiumi, H. Tanaka, T. Mimura, K. Nobutani, and et al. Neonatal Fc receptor for IgG (FcRn) expressed in the gastric epithelium regulates bacterial infection in mice Mucosal Immunol 5 1 2012 87 98
22. M. Bern, K.M.K. Sand, J. Nilsen, I. Sandlie, and J.T. Andersen The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery J Control Release 211 2015 144 162
23. A.J. Bitonti, J.A. Dumont, S.C. Low, R.T. Peters, K.E. Kropp, V.J. Palombella, and et al. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway Proc Natl Acad Sci U S A 101 26 2004 9763 9768
24. J. Borvak, J. Richardson, C. Medesan, F. Antohe, C. Radu, M. Simionescu, and et al. Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice Int Immunol 10 9 1998 1289 1298
25. P.O. Box, and B. Birmingham Transcytosis and paracellular movements of horseradish peroxidase across liver parenchymal tissue from blood to bile Biochem J 229 1985 529 537
26. F.W. Brambell The transmission of immune globulins from the mother to the foetal and newborn young Proc Nutr Soc 28 1 1969 35 41
27. F.W. Brambell, W.A. Hemmings, and I.G. Morris A theoretical model of gamma-globulin catabolism Nature 203 1964 1352 1354
28. L. Brannon-Peppas Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery Int J Pharm 116 1 1995 1 9
29. L. Brimberg, S. Mader, Y. Fujieda, Y. Arinuma, C. Kowal, B.T. Volpe, and et al. Antibodies as mediators of brain pathology Trends Immunol 36 11 2015 709 724
30. M. Buljan, D. Nemet, B. Golubic-Cepulic, G. Bicanic, B. Tripkovic, and D. Delimar Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty Int Orthop 36 4 2012 703 709
31. W.P. Burmeister, A.H. Huber, and P.J. Bjorkman Crystal structure of the complex of rat neonatal Fc receptor with Fc Nature 372 6504 1994 379 383
32. D.J. Capon, S.M. Chamow, J. Mordenti, S.A. Marsters, T. Gregory, H. Mitsuya, and et al. Designing CD4 immunoadhesins for AIDS therapy Nature 337 6207 1989 525 531
33. K. Cauza, G. Hinterhuber, R. Dingelmaier-Hovorka, K. Brugger, G. Klosner, R. Horvat, and et al. Expression of FcRn, the MHC class I-related receptor for IgG, in human keratinocytes J Invest Dermatol 124 1 2005 132 139
34. D.K. Challa, R. Velmurugan, R.J. Ober, and E. Sally Ward FcRn: From molecular interactions to regulation of IgG pharmacokinetics and functions Curr Top Microbiol Immunol 382 2014 249 272
35. C. Chaudhury, C.L. Brooks, D.C. Carter, J.M. Robinson, and C.L. Anderson Albumin binding to FcRn: Distinct from the FcRn - IgG interaction Biochemistry 45 2006 4983 4990
36. C. Chaudhury, S. Mehnaz, J.M. Robinson, W.L. Hayton, D.K. Pearl, D.C. Roopenian, and et al. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan J Exp Med 197 3 2003 315 322
37. Y. Chen, and J.P. Balthasar Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn AAPS J 14 4 2012 850 859
38. P. Cianga, C. Cianga, L. Cozma, E.S. Ward, and E. Carasevici The MHC class I related Fc receptor, FcRn, is expressed in the epithelial cells of the human mammary gland Hum Immunol 64 12 2003 1152 1159
39. P. Cianga, C. Cianga, P. Plamadeala, D. Branisteanu, and E. Carasevici The neonatal Fc receptor (FcRn) expression in the human skin Virchows Arch 451 4 2007 859 860
40. P. Cianga, C. Medesan, J.A. Richardson, V. Ghetie, and E.S. Ward Identification and function of neonatal Fc receptor in mammary gland of lactating mice Eur J Immunol 29 8 1999 2515 2523
41. I. Cucinotto, L. Fiorillo, S. Gualtieri, M. Arbitrio, D. Ciliberto, N. Staropoli, and et al. Nanoparticle albumin bound paclitaxel in the treatment of human cancer: Nanodelivery reaches prime-time? J Drug Deliv 2013 905091 2013 10
42. D.M. Czajkowsky, J. Hu, Z. Shao, and R.J. Pleass Fc-fusion proteins: New developments and future perspectives EMBO Mol Med 4 10 2012 1015 1028
43. W.F. Dall'Acqua, P.A. Kiener, and H. Wu Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn) J Biol Chem 281 33 2006 23514 23524
44. A. Datta-Mannan, J. Lu, D.R. Witcher, D. Leung, Y. Tang, and V.J. Wroblewski The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies MAbs 7 6 2015 1084 1093
45. H.L. Deissler, G.K. Lang, and G.E. Lang Internalization of bevacizumab by retinal endothelial cells and its intracellular fate: Evidence for an involvement of the neonatal Fc receptor Exp Eye Res 143 2016 49 59
46. W.L. DeLano, M.H. Ultsch, A.M. de Vos, and J.A. Wells Convergent solutions to binding at a protein-protein interface Science 287 5456 2000 1279 1283
47. C. Desnos, S. Huet, and F. Darchen "Should I stay or should I go?": Myosin V function in organelle trafficking Biol Cell 99 8 2007 411 423
48. S.C. Devanaboyina, S.M. Lynch, R.J. Ober, S. Ram, D. Kim, A. Puig-Canto, and et al. The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics MAbs 5 6 2013 851 859
49. B. Devriendt, B.G. De Geest, B.M. Goddeeris, and E. Cox Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery J Control Release 160 3 2012 431 439
50. B.L. Dickinson, K. Badizadegan, Z. Wu, J.C. Ahouse, X. Zhu, N.E. Simister, and et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line J Clin Invest 104 7 1999 903 911
51. J. a Dumont, A.J. Bitonti, D. Clark, S. Evans, M. Pickford, and S.P. Newman Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway J Aerosol Med 18 3 2005 294 303
52. J.A. Dumont, S.C. Low, R.T. Peters, and A.J. Bitonti Monomeric Fc fusions: Impact on pharmacokinetic and biological activity of protein therapeutics BioDrugs 20 3 2006 151 160
53. K. Elkon, and P. Casali Nature and functions of autoantibodies Nat Clin Pract Rheumatol 4 9 2008 491 498
54. S. Elliott, J. Egrie, J. Browne, T. Lorenzini, L. Busse, N. Rogers, and et al. Control of rHuEPO biological activity: The role of carbohydrate Exp Hematol 32 12 2004 1146 1155
55. S. Elliott, T. Lorenzini, S. Asher, K. Aoki, D. Brankow, L. Buck, and et al. Enhancement of therapeutic protein in vivo activities through glycoengineering Nat Biotechnol 21 4 2003 414 421
56. B. Elsadek, and F. Kratz Impact of albumin on drug delivery - new applications on the horizon J Control Release 157 1 2012 4 28
57. A.O. Elzoghby, W.M. Samy, and N.A. Elgindy Albumin-based nanoparticles as potential controlled release drug delivery systems J Control Release Off J Control Release Soc 157 2 2012 168 182
58. L.M. Ensign, R. Cone, and J. Hanes Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers Adv Drug Deliv Rev 64 6 2012 557 570
59. S. Feng, Y. Gong, G. Adilijiang, and H. Deng Effects of the Fc-III tag on activity and stability of green fluorescent protein and human muscle creatine kinase Protein Sci A Publ Protein Soc A Publ Protein Soc 22 7 2013 1008 1015
60. M. Firan, R. Bawdon, C. Radu, R.J. Ober, D. Eaken, F. Antohe, and et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans Int Immunol 13 8 2001 993 1002
61. S. Foss, A. Grevys, K.M.K. Sand, M. Bern, P. Blundell, T.E. Michaelsen, and et al. Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization J Control Release 223 2016 42 52
62. S. Foss, R. Watkinson, I. Sandlie, L.C. James, and J.T. Andersen TRIM21: A cytosolic Fc receptor with broad antibody isotype specificity Immunol Rev 268 1 2015 328 339
63. T. Fritzsche, M. Schnolzer, S. Fiedler, M. Weigand, M. Wiessler, and E. Frei Isolation and identification of heterogeneous nuclear ribonucleoproteins (hnRNP) from purified plasma membranes of human tumour cell lines as albumin-binding proteins Biochem Pharmacol 67 4 2004 655 665
64. K. Gadkar, C.V. Pastuskovas, J.E. Le Couter, J.M. Elliott, J. Zhang, C.V. Lee, and et al. Design and pharmacokinetic characterization of novel antibody formats for ocular therapeutics Invest Ophthalmol Vis Sci 56 9 2015 5390 5400
65. A. Garg, and J.P. Balthasar Investigation of the influence of FcRn on the distribution of IgG to the brain AAPS J 11 3 2009 553 557
66. L.N. Gastinel, N.E. Simister, and P.J. Bjorkman Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules Proc Natl Acad Sci U S A 89 1992 638 642
67. K.E. Getman, and J.P. Balthasar Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: Implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions J Pharm Sci 94 4 2005 718 729
68. V. Ghetie, and E.S. Ward Multiple roles for the major histocompatibility complex class I-related receptor FcRn Annu Rev Immunol 18 2000 739 766
69. V. Ghetie, J.G. Hubbard, J.K. Kim, M.F. Tsen, Y. Lee, and E.S. Ward Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice Eur J Immunol 26 3 1996 690 696
70. N. Ghinea, A. Fixman, D. Alexandru, D. Popov, M. Hasu, L. Ghitescu, and et al. Identification of albumin-binding proteins in capillary endothelial cells J Cell Biol 107 1 1988 231 239
71. R.K. Gill, S. Mahmood, C.P. Sodhi, J.P. Nagpaul, and A. Mahmood IgG binding and expression of its receptor in rat intestine during postnatal development Indian J Biochem Biophys 36 4 1999 252 257
72. N.A. Goebl, C.M. Babbey, A. Datta-Mannan, D.R. Witcher, V.J. Wroblewski, and K.W. Dunn Neonatal Fc receptor mediates internalization of Fc in transfected human endothelial cells Mol Biol Cell 19 12 2008 5490 5505
73. R. Gong, Y. Wang, Y. Feng, Q. Zhao, and D.S. Dimitrov Shortened engineered human antibody CH2 domains: Increased stability and binding to the human neonatal Fc receptor J Biol Chem 286 31 2011 27288 27293
74. W.J. Gradishar Albumin-bound paclitaxel: A next-generation taxane Expert Opin Pharmacother 7 8 2006 1041 1053
75. J.H. Grubb, C. Vogler, Y. Tan, G.N. Shah, A.F. MacRae, and W.S. Sly Infused Fc-tagged β-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice Proc Natl Acad Sci U S A 105 24 2008 8375 8380
76. J.A. Hammer 3rd, and J.R. Sellers Walking to work: Roles for class V myosins as cargo transporters Nat Rev Mol Cell Biol 13 1 2012 13 26
77. W.L. Hand, and J.R. Cantey Antibacterial mechanisms of the lower respiratory tract. I. immunoglobulin synthesis and secretion J Clin Invest 53 2 1974 354 362
78. J.P. Haymann, J.P. Levraud, S. Bouet, V. Kappes, J. Hagege, G. Nguyen, and et al. Characterization and localization of the neonatal Fc receptor in adult human kidney J Am Soc Nephrol 11 4 2000 632 639
79. C. Herring, and O. Schon AlbudAb™ technology platform-versatile albumin binding domains for the development of therapeutics with Tunable half-lives Therapeutic proteins 2012 Wiley-VCH Verlag GmbH & Co. KGaA 249 268
80. E.M. Hersh, S.J. O'Day, A. Ribas, W.E. Samlowski, M.S. Gordon, D.E. Shechter, and et al. A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma Cancer 116 1 2010 155 163
81. R.H. Hinton, D. Benford, L.J. Shaw, and B.M. Mullock Receptor-mediated transfer of proteins from blood to bile Trends Biochem Sci 6 1981 188 191
82. P.R. Hinton, J.M. Xiong, M.G. Johlfs, M.T. Tang, S. Keller, and N. Tsurushita An engineered human IgG1 antibody with longer serum half-life J Immunol 176 1 2006 346 356
83. P. Home, and P. Kurtzhals Insulin detemir: From concept to clinical experience Expert Opin Pharmacother 7 3 2006 325 343
84. P.J. Hornby, P.R. Cooper, C. Kliwinski, E. Ragwan, J.R. Mabus, B. Harman, and et al. Human and non-human primate intestinal FcRn expression and immunoglobulin G transcytosis Pharm Res 31 4 2014 908 922
85. C. Huang Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology Curr Opin Biotechnol 20 6 2009 692 699
86. E.E. Idusogie, L.G. Presta, H. Gazzano-Santoro, K. Totpal, P.Y. Wong, M. Ultsch, and et al. Mapping of the C1q binding site on Rituxan, a chimeric antibody with a human IgG1 Fc J Immunol 164 8 2000 4178 4184
87. T. Igawa, A. Maeda, K. Haraya, T. Tachibana, Y. Iwayanagi, F. Mimoto, and et al. Engineered monoclonal antibody with novel antigen-sweeping activity in vivo PLoS One 8 5 2013 e63236
88. E.J. Israel, V.K. Patel, S.F. Taylor, A. Marshak-Rothstein, and N.E. Simister Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice J Immunol 154 12 1995 6246 6251
89. E.J. Israel, S. Taylor, Z. Wu, E. Mizoguchi, R.S. Blumberg, A. Bhan, and et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells Immunology 92 1997 69 74
90. J.S. Jaggi, J.A. Carrasquillo, S.V. Seshan, P. Zanzonico, E. Henke, A. Nagel, and et al. Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor J Clin Invest 117 9 2007 2422 2430
91. R. Jahn, T. Lang, and T.C. Südhof Membrane fusion Cell 112 4 2003 519 533
92. M.J. John, V. Jaison, K. Jain, N. Kakkar, and J.J. Jacob Erythropoietin use and abuse Indian J Endocrinol Metab 16 2 2012 220 227
93. A. Jonsson, J. Dogan, N. Herne, L. Abrahmsen, and P.-A. Nygren Engineering of a femtomolar affinity binding protein to human serum albumin Protein Eng Des Sel 21 8 2008 515 527
94. M. Joyeux-Faure Cellular protection by erythropoietin: New therapeutic implications? J Pharmacol Exp Ther 323 3 2007 759 762
95. R.P. Junghans, and C.L. Anderson The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor Proc Natl Acad Sci U S A 93 11 1996 5512 5516
96. J. Kim, C.L. Bronson, W.L. Hayton, M.D. Radmacher, D.C. Roopenian, J.M. Robinson, and et al. Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces Am J Physiol Gastrointest Liver Physiol 290 2 2006 G352 G360
97. H. Kim, R.N. Fariss, C. Zhang, S.B. Robinson, M. Thill, and K.G. Csaky Mapping of the neonatal Fc receptor in the rodent eye Invest Ophthalmol Vis Sci 49 5 2008 2025 2029
98. J.K. Kim, M. Firan, C.G. Radu, C.H. Kim, V. Ghetie, and E.S. Ward Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn Eur J Immunol 29 9 1999 2819 2825
99. J. Kim, W.L. Hayton, J.M. Robinson, and C.L. Anderson Kinetics of FcRn-mediated recycling of IgG and albumin in human: Pathophysiology and therapeutic implications using a simplified mechanism-based model Clin Immunol 122 2 2007 146 155
100. J.K. Kim, M.F. Tsen, V. Ghetie, and E.S. Ward Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor Eur J Immunol 24 10 1994 2429 2434
101. J.K. Kim, M.F. Tsen, V. Ghetie, and E.S. Ward Catabolism of the murine IgG1 molecule: Evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice Scand J Immunol 40 4 1994 457 465
102. J.K. Kim, M.F. Tsen, V. Ghetie, and E.S. Ward Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis Eur J Immunol 24 3 1994 542 548
103. C. Kliwinski, P.R. Cooper, R. Perkinson, J.R. Mabus, S.H. Tam, T.M. Wilkinson, and et al. Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice Am J Physiol Gastrointest Liver Physiol 304 31 2013 G262 G270
104. R.A. Knee, D.K. Hickey, K.W. Beagley, and R.C. Jones Transport of IgG across the blood-luminal barrier of the male reproductive tract of the rat and the effect of estradiol administration on reabsorption of fluid and IgG by the epididymal ducts Biol Reprod 73 4 2005 688 694
105. S.-Y. Ko, A. Pegu, R.S. Rudicell, Z.-Y. Yang, M.G. Joyce, X. Chen, and et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection Nature 514 7524 2014 642 645
106. L.A. Kottschade, V.J. Suman, T. Amatruda 3rd, R.R. McWilliams, B.I. Mattar, D.A. Nikcevich, and et al. A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma: A North Central Cancer Treatment Group Study, N057E(1) Cancer 117 8 2011 1704 1710
107. L.A. Kottschade, V.J. Suman, D.G. Perez, R.R. McWilliams, J.S. Kaur, T.T. Amatruda 3rd, and et al. A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma: A North Central Cancer Treatment Group Study, N0775 Cancer 119 3 2013 586 592
108. F. Kratz Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles J Control Release 132 3 2008 171 183
109. F. Kratz A clinical update of using albumin as a drug vehicle - A commentary J Control Release 190 2014 331 336
110. T.T. Kuo, and V.G. Aveson Neonatal Fc receptor and IgG-based therapeutics MAbs 3 5 2011 422 430
111. T.T. Kuo, K. Baker, M. Yoshida, S.W. Qiao, V.G. Aveson, W.I. Lencer, and et al. Neonatal Fc receptor: From immunity to therapeutics J Clin Immunol 30 6 2010 777 789
112. J.L. Leach, D.D. Sedmak, J.M. Osborne, B. Rahill, M.D. Lairmore, and C.L. Anderson Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: Implications for maternal-fetal antibody transport J Immunol 157 8 1996 3317 3322
113. R. Léger, K. Thibaudeau, M. Robitaille, O. Quraishi, P. van Wyk, N. Bousquet-Gagnon, and et al. Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7-36) analog Bioorg Med Chem Lett 14 17 2004 4395 4398
114. R.D. Leslie, J. Palmer, N.C. Schloot, and A. Lernmark Diabetes at the crossroads: Relevance of disease classification to pathophysiology and treatment Diabetologia 59 1 2015 13 20
115. Z. Li, S. Palaniyandi, R. Zeng, W. Tuo, D.C. Roopenian, and X. Zhu Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection Proc Natl Acad Sci U S A 108 11 2011 4388 4393
116. N. Li, M. Zhao, J. Hilario-Vargas, P. Prisayanh, S. Warren, L.A. Diaz, and et al. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases J Clin Invest 115 12 2005 3440 3450
117. C. Linker Plasmapheresis in clinical medicine West J Med 138 1 1983 60 69
118. L. Liu, A.M. Garcia, H. Santoro, Y. Zhang, K. McDonnell, J. Dumont, and et al. Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade J Immunol 178 8 2007 5390 5398
119. X. Liu, L. Lu, Z. Yang, S. Palaniyandi, R. Zeng, L.-Y. Gao, and et al. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells J Immunol 186 8 2011 4674 4686
120. S. Loubery, and E. Coudrier Myosins in the secretory pathway: Tethers or transporters? Cell Mol Life Sci 65 18 2008 2790 2800
121. S.C. Low, S.L. Nunes, A.J. Bitonti, and J.A. Dumont Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis Hum Reprod 20 7 2005 1805 1813
122. T. Martins, T. Burgoyne, B.-A. Kenny, N. Hudson, C.E. Futter, A.F. Ambrósio, and et al. Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells Neuropharmacology 65 2013 74 82
123. K.M. McCarthy, Y. Yoong, and N.E. Simister Bidirectional transcytosis of IgG by the rat neonatal Fc receptor expressed in a rat kidney cell line: A system to study protein transport across epithelia J Cell Sci 113 2000 1277 1285
124. C. Medesan, D. Matesoi, C. Radu, V. Ghetie, and E.S. Ward Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1 J Immunol 158 5 1997 2211 2217
125. A.M. Merlot, D.S. Kalinowski, and D.R. Richardson Unraveling the mysteries of serum albumin - more than just a serum protein Front Physiol 5 2014 299
126. A.R. Mezo, K.A. McDonnell, C.A.T. Hehir, S.C. Low, V.J. Palombella, J.M. Stattel, and et al. Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn Proc Natl Acad Sci U S A 105 7 2008 2337 2342
127. A.R. Mezo, V. Sridhar, J. Badger, P. Sakorafas, and V. Nienaber X-ray crystal structures of monomeric and dimeric peptide inhibitors in complex with the human neonatal Fc receptor, FcRn J Biol Chem 285 36 2010 27694 27701
128. M. Miaczynska, and M. Zerial Mosaic organization of the endocytic pathway Exp Cell Res 272 1 2002 8 14
129. E. Miele, G.P. Spinelli, E. Miele, F. Tomao, and S. Tomao Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer Int J Nanomedicine 4 1 2009 99 105
130. J. Monks, and M.C. Neville Albumin transcytosis across the epithelium of the lactating mouse mammary gland J Physiol 560 Pt 1 2004 267 280
131. H.P. Montoyo, C. Vaccaro, M. Hafner, R.J. Ober, W. Mueller, and E.S. Ward Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice Proc Natl Acad Sci U S A 106 8 2009 2788 2793
132. L.W. Moreland Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis Rheum Dis Clin N Am 24 3 1998 579 591
133. B. Mouratou, G. Béhar, and F. Pecorari Artificial affinity proteins as ligands of immunoglobulins Biomolecules 5 1 2015 60 75
134. K. Nakata, K. Kobayashi, Y. Ishikawa, M. Yamamoto, Y. Funada, Y. Kotani, and et al. The transfer of maternal antigen-specific IgG regulates the development of allergic airway inflammation early in life in an FcRn-dependent manner Biochem Biophys Res Commun 395 2 2010 238 243
135. T. Neuber, K. Frese, J. Jaehrling, S. Jäger, D. Daubert, K. Felderer, and et al. Characterization and screening of IgG binding to the neonatal Fc receptor MAbs 6 4 2014 928 942
136. A. Nguyen, A.E. Reyes 2nd, M. Zhang, P. McDonald, W.L.T. Wong, L.A. Damico, and et al. The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin Protein Eng Des Sel 19 7 2006 291 297
137. Y. Niwa, A. Iio, G. Niwa, T. Sakane, T. Tsunematsu, and T. Kanoh Serum albumin metabolism in rheumatic diseases: Relationship to corticosteroids and peptic ulcer J Clin Lab Immunol 31 1 1990 11 16
138. R.J. Ober, C. Martinez, X. Lai, J. Zhou, and E.S. Ward Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single-molecule level Proc Natl Acad Sci U S A 101 30 2004 11076 11081
139. R.J. Ober, C. Martinez, C. Vaccaro, J. Zhou, and E.S. Ward Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn J Immunol 172 4 2004 2021 2029
140. R.J. Ober, C.G. Radu, V. Ghetie, and E.S. Ward Differences in promiscuity for antibody-FcRn interactions across species: Implications for therapeutic antibodies Int Immunol 13 12 2001 1551 1559
141. V. Oganesyan, M.M. Damschroder, K.E. Cook, Q. Li, C. Gao, H. Wu, and et al. Structural insights into neonatal Fc receptor-based recycling mechanisms J Biol Chem 289 11 2014 7812 7824
142. P. Palmeira, C. Quinello, A.L. Silveira-Lessa, C.A. Zago, and M. Carneiro-Sampaio IgG placental transfer in healthy and pathological pregnancies Clin Dev Immunol 2012 2012 985646
143. G.V. Patil Biopolymer albumin for diagnosis and in drug delivery Drug Dev Res 58 3 2003 219 247
144. C.A. Penno, Y. Kawabe, A. Ito, and M. Kamihira Production of recombinant human erythropoietin/Fc fusion protein by genetically manipulated chickens Transgenic Res 19 2010 187 195
145. C. Pereira, F. Araújo, C.C. Barrias, P.L. Granja, and B. Sarmento Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies Biomaterials 56 2015 36 45
146. T. Peters Jr. 4 - Genetics: The albumin gene T.B.T.-A.A.A. Peters, All about albumin 1995 Academic Press San Diego 133 187
147. S.B. Petkova, S. Akilesh, T.J. Sproule, G.J. Christianson, H. Al Khabbaz, A.C. Brown, and et al. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: Potential application in humorally mediated autoimmune disease Int Immunol 18 12 2006 1759 1769
148. F. Petrelli, K. Borgonovo, and S. Barni Targeted delivery for breast cancer therapy: The history of nanoparticle-albumin-bound paclitaxel Expert Opin Pharmacother 11 8 2010 1413 1432
149. A.F. Pike, N.I. Kramer, B.J. Blaauboer, W. Seinen, and R. Brands A novel hypothesis for an alkaline phosphatase "rescue" mechanism in the hepatic acute phase immune response Biochim Biophys Acta Mol basis Dis 1832 12 2013 2044 2056
150. D. Plaksin, K. Polakova, M.G. Mage, and D.H. Margulies Rigidification of the alpha2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation J Immunol 159 9 1997 4408 4414
151. S. Popov, J.G. Hubbard, J. Kim, B. Ober, V. Ghetie, and E.S. Ward The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn Mol Immunol 33 6 1996 521 530
152. M.B. Powner, J.A.G. McKenzie, G.J. Christianson, D.C. Roopenian, and M. Fruttiger Expression of neonatal Fc receptor in the eye Invest Ophthalmol Vis Sci 55 3 2014 1607 1615
153. P. Prabhat, Z. Gan, J. Chao, S. Ram, C. Vaccaro, S. Gibbons, and et al. Elucidation of intracellular recycling pathways leading to exocytosis of the Fc receptor, FcRn, by using multifocal plane microscopy Proc Natl Acad Sci U S A 104 14 2007 5889 5894
154. E.M. Pridgen, F. Alexis, T.T. Kuo, E. Levy-Nissenbaum, R. Karnik, R.S. Blumberg, and et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery Sci Transl Med 5 2013 213ra167
155. G. Proetzel, and D.C. Roopenian Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies Methods 65 1 2014 148 153
156. G. Proetzel, M.V. Wiles, and D.C. Roopenian Genetically engineered humanized mouse models for preclinical antibody studies BioDrugs 28 2 2014 171 180
157. M. Raghavan, V.R. Bonagura, S.L. Morrison, and P.J. Bjorkman Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants Biochemistry 34 45 1995 14649 14657
158. M. Raghavan, M.Y. Chen, L.N. Gastinel, and P.J. Bjorkman Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand Immunity 1 4 1994 303 315
159. M. Raghavan, L.N. Gastinel, and P.J. Bjorkman The class I major histocompatibility complex related Fc receptor shows pH-dependent stability differences correlating with immunoglobulin binding and release Biochemistry 32 33 1993 8654 8660
160. T. Rath, K. Baker, J.a. Dumont, R.T. Peters, H. Jiang, S.-W. Qiao, and et al. Fc-fusion proteins and FcRn: Structural insights for longer-lasting and more effective therapeutics Crit Rev Biotechnol 35 2 2015 235 254
161. T. Rath, K. Baker, M. Pyzik, and R.S. Blumberg Regulation of immune responses by the neonatal Fc receptor and its therapeutic implications Front Immunol 5 2014
162. T. Rath, T.T. Kuo, K. Baker, S.W. Qiao, K. Kobayashi, M. Yoshida, and et al. The immunologic functions of the neonatal Fc receptor for IGG J Clin Immunol 33 SUPPL.1 2013 9 17
163. D.M. Roberts, M. Guenthert, and R. Rodewald Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat J Cell Biol 111 5 I 1990 1867 1876
164. R. Rodewald pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat J Cell Biol 71 2 1976 666 669
165. D.C. Roopenian, and S. Akilesh FcRn: The neonatal Fc receptor comes of age Nat Rev Immunol 7 August 2007 715 725
166. D.C. Roopenian, G.J. Christianson, T.J. Sproule, A.C. Brown, S. Akilesh, N. Jung, and et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs J Immunol 170 7 2003 3528 3533
167. D.C. Roopenian, B.E. Low, G.J. Christianson, G. Proetzel, T.J. Sproule, and M.V. Wiles Albumin-deficient mouse models for studying metabolism of human albumin and pharmacokinetics of albumin-based drugs MAbs 7 2 2015 344 351
168. E.R. Salgado, R. Montesino, S.P. Jimenez, M. Gonzalez, F. Hugues, O.I. Cabezas, and et al. Post-translational modification of a chimeric EPO-Fc hormone is more important than its molecular size in defining its in vivo hematopoietic activity Biochim Biophys Acta 1850 9 2015 1685 1693
169. L.M. Sánchez, D.M. Penny, and P.J. Bjorkman Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand Biochemistry 38 29 1999 9471 9476
170. K.M.K. Sand, M. Bern, J. Nilsen, H.T. Noordzij, I. Sandlie, and J.T. Andersen Unraveling the interaction between FcRn and albumin: Opportunities for design of albumin-based therapeutics Front Immunol 5 January 2015 1 21
171. K.M.K. Sand, B. Dalhus, G.J. Christianson, M. Bern, S. Foss, J. Cameron, and et al. Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodies J Biol Chem 289 24 2014 17228 17239
172. M. Sarav, Y. Wang, B.K. Hack, A. Chang, M. Jensen, L. Bao, and et al. Renal FcRn reclaims albumin but facilitates elimination of IgG J Am Soc Nephrol 20 9 2009 1941 1952
173. F. Schlachetzki, C. Zhu, and W.M. Pardridge Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier J Neurochem 81 1 2002 203 206
174. M.M. Schmidt, S.A. Townson, A.J. Andreucci, B.M. King, E.B. Schirmer, A.J. Murillo, and et al. Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface Structure 21 11 2013 1966 1978
175. J.E. Schnitzer, and P. Oh Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium Am J Phys 263 6 Pt 2 1992 H1872 H1879
176. J.E. Schnitzer, W.W. Carley, and G.E. Palade Albumin interacts specifically with a 60-kDa microvascular endothelial glycoprotein Proc Natl Acad Sci U S A 85 18 1988 6773 6777
177. A. Schoch, H. Kettenberger, O. Mundigl, G. Winter, J. Engert, J. Heinrich, and et al. Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics Proc Natl Acad Sci 112 19 2015 5997 6002
178. P. Schuck, C.G. Radu, and E.S. Ward Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1 Mol Immunol 36 15-16 1999 1117 1125
179. H.E. Schultze, and J.F. Heremans Molecular biology of human proteins: With special reference to plasma proteins 1966 Elsevier Amesterdam
180. A.M. Scott, J.D. Wolchok, and L.J. Old Antibody therapy of cancer Nat Rev Cancer 12 4 2012 278 287
181. S. Sebak, M. Mirzaei, M. Malhotra, A. Kulamarva, and S. Prakash Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: Preparation and in vitro analysis Int J Nanomedicine 5 1 2010 525 532
182. J. Seijsing, M. Lindborg, I. Hoiden-Guthenberg, H. Bonisch, E. Guneriusson, F.Y. Frejd, and et al. An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein Proc Natl Acad Sci U S A 111 48 2014 17110 17115
183. A.G. Sener Autoantibodies in autoimmune liver diseases APMIS 123 11 2015 915 919
184. U. Shah, B.L. Dickinson, R.S. Blumberg, N.E. Simister, W.I. Lencer, and W.A. Walker Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine Pediatr Res 53 2 2003 295 301
185. E.J. Sharples, C. Thiemermann, and M.M. Yaqoob Novel applications of recombinant erythropoietin Curr Opin Pharmacol 6 2 2006 184 189
186. X. Shi, J. Yang, H. Zhu, L. Ye, M. Feng, J. Li, and et al. Pharmacokinetics and pharmacodynamics of recombinant human EPO-Fc fusion protein in vivo PLoS One 8 8 2013 e72673
187. R.L. Shields, A.K. Namenuk, K. Hong, Y.G. Meng, J. Rae, J. Briggs, and et al. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R J Biol Chem 276 9 2001 6591 6604
188. N.E. Simister, and K.E. Mostov An Fc receptor structurally related to MHC class I antigens Nature 337 6203 1989 184 187
189. N.E. Simister, C.M. Story, H.L. Chen, and J.S. Hunt An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta Eur J Immunol 26 7 1996 1527 1531
190. D. Sleep Albumin and its application in drug delivery Expert Opin Drug Deliv 12 5 2015 793 812
191. D. Sleep, J. Cameron, and L.R. Evans Albumin as a versatile platform for drug half-life extension Biochim Biophys Acta 1830 12 2013 5526 5534
192. J.T. Sockolosky, and F.C. Szoka The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy Adv Drug Deliv Rev 91 30 2015 109 124
193. J.T. Sockolosky, S. Kivimae, and F.C. Szoka Fusion of a short peptide that binds immunoglobulin G to a recombinant protein substantially increases its plasma half-life in mice PLoS One 9 7 2014 e102566
194. Somsel Rodman, J., Wandinger-Ness, A., 2000. Rab GTPases coordinate endocytosis. J Cell Sci 113 Pt 2 pp. 183-192.
195. G.M. Spiekermann, P.W. Finn, E.S. Ward, J. Dumont, B.L. Dickinson, R.S. Blumberg, and et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung J Exp Med 196 3 2002 303 310
196. N.M. Stapleton, H.K. Einarsdóttir, A.M. Stemerding, and G. Vidarsson The multiple facets of FcRn in immunity Immunol Rev 268 1 2015 253 268
197. G. Stehle, H. Sinn, A. Wunder, H.H. Schrenk, J.C. Stewart, G. Hartung, and et al. Plasma protein (albumin) catabolism by the tumor itself - implications for tumor metabolism and the genesis of cachexia Crit Rev Oncol Hematol 26 2 1997 77 100
198. C. Stein, L. Kling, G. Proetzel, D.C. Roopenian, M.H. de Angelis, E. Wolf, and et al. Clinical chemistry of human FcRn transgenic mice Mamm Genome 23 3-4 2012 259 269
199. E.-M. Strauch, S.J. Fleishman, and D. Baker Computational design of a pH-sensitive IgG binding protein Proc Natl Acad Sci U S A 111 2 2014 675 680
200. W.R. Strohl Fusion proteins for half-life extension of biologics as a strategy to make biobetters BioDrugs 29 4 2015 215 239
201. J.H. Suh, and J.H. Miner The glomerular basement membrane as a barrier to albumin Nat Rev Nephrol 9 8 2013 470 477
202. P.S. Sullivan, D.L. Hanson, J.T. Richardson, and J.T. Brooks Trends in the treatment of anemia using recombinant human erythropoietin in patients with HIV infection Open AIDS J 5 2011 113 118
203. R. Swiercz, S. Chiguru, A. Tahmasbi, S.M. Ramezani, G. Hao, D.K. Challa, and et al. Use of Fc-engineered antibodies as clearing agents to increase contrast during PET J Nucl Med 55 7 2014 1204 1207
204. S.H. Tam, S.G. McCarthy, K. Brosnan, K.M. Goldberg, and B.J. Scallon Correlations between pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model with predictive capabilities MAbs 5 3 2013 397 405
205. A. Tamburrini, F. Tacconi, A.C. Barlattani, and T. Mineo An update on myasthenia gravis, challenging disease for the dental profession J Oral Sci 57 3 2015 161 168
206. Z. Tian, B.J. Sutton, and X. Zhang Distribution of rat neonatal Fc receptor in the principal organs of neonatal and pubertal rats J Recept Signal Transduct Res 9893 2 2014 1 6
207. P.L. Tuma, and A.L. Hubbard Transcytosis: Crossing cellular barriers Physiol Rev 83 2003 871 932
208. S. Tzaban, R.H. Massol, E. Yen, W. Hamman, S.R. Frank, L.A. Lapierre, and et al. The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity J Cell Biol 185 4 2009 673 684
209. C. Vaccaro, R. Bawdon, S. Wanjie, R.J. Ober, and E.S. Ward Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies Proc Natl Acad Sci U S A 103 49 2006 18709 18714
210. C. Vaccaro, J. Zhou, R.J. Ober, and E.S. Ward Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels Nat Biotechnol 23 10 2005 1283 1288
211. D.E. Vaughn, and P.J. Bjorkman Structural basis of pH-dependent antibody binding by the neonatal Fc receptor Structure 6 1 1998 63 73
212. D.E. Vaughn, C.M. Milburn, D.M. Penny, W.L. Martin, J.L. Johnson, and P.J. Bjorkman Identification of critical IgG binding epitopes on the neonatal Fc receptor J Mol Biol 274 4 1997 597 607
213. M.J. Vazquez-Mellado, C. Aguilar, and L. Rocha-Zavaleta Erythropoietin protects neuroblastoma cells against etoposide and vincristine by activating ERK and AKT pathways but has no effect in kidney cells Life Sci 137 2015 142 149
214. D. Viuff, F. Antunes, L. Evans, J. Cameron, H. Dyrnesli, B. Thue Ravn, and et al. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs J Control Release 223 2016 22 30
215. D. Vllasaliu, C. Alexander, M. Garnett, M. Eaton, and S. Stolnik Fc-mediated transport of nanoparticles across airway epithelial cell layers J Control Release 158 3 2012 479 486
216. Z. Wang, C. Fraley, and A.R. Mezo Discovery and structure-activity relationships of small molecules that block the human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction Bioorg Med Chem Lett 23 5 2013 1253 1256
217. Y. Wang, Z. Tian, D. Thirumalai, and X. Zhang Neonatal Fc receptor (FcRn): A novel target for therapeutic antibodies and antibody engineering J Drug Target 22 4 2014 269 278
218. E.S. Ward, and R.J. Ober Multitasking by exploitation of intracellular transport functions the many faces of FcRn Advances in immunology 2009 Elsevier Inc. United States 77 115 10.1016/S0065-2776(09)03004-1
219. P.M.D. Watson, J.C. Paterson, G. Thom, U. Ginman, S. Lundquist, and C.I. Webster Modelling the endothelial blood-CNS barriers: A method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier BMC Neurosci 14 1 2013 59
220. A.W. Weflen, N. Baier, Q.-J. Tang, M. Van den Hof, R.S. Blumberg, W.I. Lencer, and et al. Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules Mol Biol Cell 24 15 2013 2398 2405
221. A.P.J. West, and P.J. Bjorkman Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor Biochemistry 39 32 2000 9698 9708
222. P. Wilkinson, R. Jeremy, F.P. Brooks, and J.L. Hollander The mechanism of hypoalbuminemia in rheumatoid arthritis Ann Intern Med 63 1965 109 114
223. L. Ye, R. Zeng, Y. Bai, D.C. Roopenian, and X. Zhu Efficient mucosal vaccination mediated by the neonatal Fc receptor Nat Biotechnol 29 2 2011 158 163
224. Y.A. Yeung, X. Wu, A.E. Reyes 2nd, J.-M. Vernes, S. Lien, J. Lowe, and et al. A therapeutic anti-VEGF antibody with increased potency independent of pharmacokinetic half-life Cancer Res 70 8 2010 3269 3277
225. T. Ying, W. Chen, Y. Feng, Y. Wang, R. Gong, and D.S. Dimitrov Engineered soluble monomeric IgG1 CH3 domain generation, mechanisms of function, and implications for design of biological therapeutics J Biol Chem 288 35 2013 25154 25164
226. V. Yip, E. Palma, D.B. Tesar, E.E. Mundo, D. Bumbaca, E.K. Torres, and et al. Quantitative cumulative biodistribution of antibodies in mice: Effect of modulating binding affinity to the neonatal Fc receptor MAbs 6 3 2014 689 696
227. M. Yoshida, S.M. Claypool, J.S. Wagner, E. Mizoguchi, A. Mizoguchi, D.C. Roopenian, and et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells Immunity 20 2004 769 783
228. M. Yoshida, K. Kobayashi, T.T. Kuo, L. Bry, J.N. Glickman, S.M. Claypool, and et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria J Clin Invest 116 8 2006 2142 2151
229. J. Zalevsky, A.K. Chamberlain, H.M. Horton, S. Karki, I.W.L. Leung, T.J. Sproule, and et al. Enhanced antibody half-life improves in vivo activity Nat Biotechnol 28 2 2010 157 159
230. X.Y. Zhai, R. Nielsen, H. Birn, K. Drumm, S. Mildenberger, R. Freudinger, and et al. Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney Kidney Int 58 4 2000 1523 1533
231. Y. Zheng, H. Scheerens, J.C.J. Davis, R. Deng, S.K. Fischer, C. Woods, and et al. Translational pharmacokinetics and pharmacodynamics of an FcRn-variant anti-CD4 monoclonal antibody from preclinical model to phase I study Clin Pharmacol Ther 89 2 2011 283 290
232. X. Zhu, G. Meng, B.L. Dickinson, X. Li, E. Mizoguchi, L. Miao, and et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells J Immunol 166 5 2001 3266 3276
233. M. Zijlstra, M. Bix, N.E. Simister, J.M. Loring, D.H. Raulet, and R. Jaenisch Beta 2-microglobulin deficient mice lack CD4-8 + cytolytic T cells Nature 344 6268 1990 742 746
234. B. Zülfikar, and B. Koç Use of intravenous immunoglobulin in pediatric practice Turkish Arch Pediatr Pediatr Arşivi 49 4 2014 282 288